News from Zyme and the companies we work with.

December 6, 17

Horizon extends industry-leading gene editing IP portfolio through expansion of CRISPR license rights with ERS Genomics

·Breadth of research use rights now expanded to include multiple new species ·Grant of rights to have products made and sold by partners ·Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland, 05 December, 2017: Horizon … Continue reading

December 6, 17

SYGNIS AG launches TruePrime apoptotic cell free DNA amplification kit for the liquid biopsy market

TruePrimE cfDNA kit offers superior selectivity and preferential amplification TruePrime cfDNA is fully scalable from small to mid-scale programs Liquid biopsy market is a fast-growing multibillion market Heidelberg, Germany and Cambridge, UK, 06 December 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: … Continue reading

December 6, 17

LifeArc appointments strengthen board of trustees

London, UK, 05 December 2017:    LifeArc®, the medical research charity, has strengthened its board by appointing three new trustees: Aisling Burnand, MBE, Chief Executive of the Association of Medical Research Charities (AMRC); Daniel Morgan; and Jessica Mann, Company Head, Cardiovascular … Continue reading

December 5, 17

Horizon Discovery introduces Multiplex cfDNA Reference Standard for EGFR mutations to support liquid biopsy assays

First-to-market cfDNA Reference Standard specific for EGFR gene mutations adds to Horizon’s existing portfolio of cfDNA controls Horizon’s EGFR Multiplex cfDNA Reference Standard allows laboratories to optimize, validate and routinely monitor performance of PCR-based tests, NGS, and other novel assays … Continue reading

December 4, 17

Cobra Biologics Wins ‘Company of the Year’ and ‘Technical Services’ Awards in Double Success at 2017 Bionow Awards

Awards recognise outstanding leaders and innovators in the life sciences sector in the North of England Keele, UK, 4th December 2017: Cobra Biologics Ltd, an international CDMO of biologics and pharmaceuticals, is very proud to have been named as Company … Continue reading

November 29, 17

SBRI Healthcare programme recognised as ‘the best role model’ in David Connell’s independent review for the government

29 November 2017:   SBRI Healthcare, an NHS England funded programme that supports innovative companies to solve healthcare problems, welcomes the release of an independent review by David Connell which examines how the UK government can maximise the impact of the … Continue reading

November 29, 17

SYGNIS AG signs supply agreement with US Biological for the Lightning-Link antibody labelling technology

Heidelberg, Germany and Cambridge, UK, 28 November 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with US Biological, … Continue reading

November 29, 17

Concept Life Sciences invests in East Kilbride analytical services facility

£250k investment doubles capacity across many service areas Manchester, UK, 29 November 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has invested £250k in new equipment at its East Kilbride analytical … Continue reading

November 28, 17

Applied Photophysics expands management team and strengthens sales and application support

Stuart Wood joins as Operations Director and Jason McClounan as Finance Manager and Company Secretary Sales Managers, Application Scientists and Service Engineer appointed across Europe and North America Surrey, UK – November 28, 2017: Applied Photophysics, a leading provider of … Continue reading

November 27, 17

Cambridge Epigenetix Appoints Professor Mark Dawson as Scientific Advisor

Cambridge, UK, 27 November 2017:   Cambridge Epigenetix (CEGX), a pioneer in the development and application of epigenetic technologies, today announced the appointment of leading epigenetics-based therapeutics specialist, Professor Mark Dawson to its Scientific Advisory Board (SAB). Professor Dawson brings a … Continue reading